Other MAJOR BENEFITS too , of course which make IMU so interesting and potentially valuable
The concept of teaching and inducing the body to generate its own antibodies against PD-1 expressing cells represents a paradigm shift in immuno-oncology, and is the first report of treating cancer by this method. A new method of treatment patent (Australian Patent Office: 2018900368) has been filed to provide protection across a broad landscape of possible immunotherapies,
The B cell approach is all about harnessing the body's own imune system to do the hard work .
Benefit 1. = Less drug product needed ( compared with alternatives )
Benefit 2 = Less cost ( much less )
Benefit 3 = Less side effects
I'm not that good at explaining all the stuff they do ............. but I would encourage any one who is remotely interested in IMU to take the time to trawl their website ...... Lots of info & there .
http://www.imugene.com/
IF you cant read - listen to the overview video
Sure its early days .......
do what you reckon is a fair thing .
- Forums
- ASX - By Stock
- IMU
- 2.85 billion shares on issue
IMU
imugene limited
Add to My Watchlist
0.00%
!
13.5¢
2.85 billion shares on issue, page-22
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
